Trabecular cell expression of fibronectin and MMP-3 is modulated by aqueous humor growth factors

Experimental Eye Research

Volumn 78, Issue 3, 2004, Pages 653-660

  Tripathi, Brenda J ^a   Tripathi, Ramesh C ^a   Chen, Jianguang ^a   Gotsis, Stelios ^a   Li, Junping ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; Glaucoma; Primary aqueous humor; Secondary aqueous humor; Trabecular meshwork; Western blot

Indexed keywords

FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GROWTH FACTOR; MESSENGER RNA; STROMELYSIN;

ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLAUCOMA; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 0842287981     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.09.011     Document Type: Article

References (52)

1. Acott T.S. Trabecular extracellular matrix regulation. Drance S.M., van Buskirk E.M., Neufeld A.H. Pharmacology of Glaucoma. 1992;125-157 Williams and Wilkins, Baltimore.
2. Acott T.S. Biochemistry of aqueous humor outflow. Podos S.M., Yanoff M., Kaufman P.L., Mittag T.W. Textbook of Ophthalmology. 1994;1.47-41.78 Mosby, St Louis.
3. Acott T.S. Biochemistry of aqueous humor outflow. Ritch R., Shields M.B., Krupin T. The Glaucomas. 2nd Ed. 1996;281-305 Mosby, St Louis.
4. Alexander J.P., Acott T.S. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest. Ophthalmol. Vis. Sci. 42:2001;2831-2838.
5. Alexander J.P., Samples J.R., Acott T.S. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr. Eye Res. 17:1998;276-285.
6. Alexander J.P., Samples J.R., van Buskirk E.M., Acott T.S. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 32:1991;172-180.
7. Babizhayev M.A., Brodskaya M.W. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open-angle glaucoma. Mech. Aging Dev. 47:1989;145-157.
8. Beaufrere L., Hauswirth W.W. Ocular gene therapy: quo vadis? Invest. Ophthalmol. Vis. Sci. 41:2000;2821-2826.
9. Bennett J., Maguire A.M. Gene therapy for ocular disease. Mol. Ther. 1:2000;501-505.
10. Bradley J.M., Vranka J., Colvis C.M., Conger D.M., Alexander J.P., Fisk A.S., Samples J.R., Acott T.S. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest. Ophthalmol. Vis. Sci. 39:1998;2649-2658.
11. Bradley J.M., Anderson A.M., Colvis C.M., Parshley D.E., Zhu X.H., Ruddat M.S., Samples J.R., Acott T.S. Mediation of laser trabeculoplasty- induced matrix metalloproteinase expression by IL-1beta and TNF alpha. Invest. Ophthalmol. Vis. Sci. 41:2000;422-430.
12. Bradley J.M.B., Kelley M.J., Zhu X., Anderssohn A.M., Alexander J.P., Acott T.S. Effects of mechanical stretching on trabecular matrix metalloproteinases. Invest. Ophthalmol. Vis. Sci. 42:2001;1505-1513.
13. Chapman S.A., Ayad S., O'Donoghue E., Bonshek R.E. Glycoproteins of trabecular meshwork, cornea and sclera. Eye. 12:1998;440-448.
14. Choi Y.I., Youn D.H., Ko M.K., Choe J.K. Fibronectin in the trabecular meshwork: immunofluorescent and immunoelectron microscopic findings. Korean J. Ophthalmol. 5:1991;1-8.
15. Clark A.F., Wilson K., De Kater A.W., Allingham R.R., McCartney M.D. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Invest. Ophthalmol. Vis. Sci. 36:1995;478-489.
16. Ehrich D., Tripathi B., Tripathi R., Duncker G. Increased hydrostatic pressure influences expression of matrix metalloproteases mRNAs by trabecular cells. Res. Commun. Pharm. Toxicol. 6:2001;107-116.
17. Floyd B.B., Cleveland P.H., Worthen D.M. Fibronectin in human trabecular drainage channels. Invest. Ophthalmol. Vis. Sci. 26:1985;797-804.
18. Gospodarowicz D. Biological activities of fibroblast growth factors. Ann. N.Y. Acad. Sci. 638:1991;1-8.
19. Halford W.P., Falco V.C., Gebhardt B.M., Carr D.J. The inherent quantitative capacity of the reverse transcriptase-polymerase chain reaction. Anal. Biochem. 266:1999;181-191.
20. Hann C.R., Springett M.J., Wang X., Johnson D.H. Ultrastructural localization of collagen IV, fibronectin, and laminin in the trabecular meshwork of normal and glaucomatous eyes. Ophthalmic Res. 33:2001;314-324.
21. Hernandez M.R., Gong H. Extracellular matrix of the trabecular meshwork and optic nerve head. Ritch R., Shields M.B., Krupin T. The Glaucomas. 2nd Ed. 1996;213-249 Mosby, St Louis.
22. Hyne R.O. Fibronectins. Hynes R.O. Fibronectin. 1990;85-175 Springer, New York.
23. Jones J.L., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
24. Kee C., Sohn S., Huwang J. Stromelysin gene transfer into cultured human trabecular cells and rat trabecular meshwork in vivo. Invest. Ophthalmol. Vis. Sci. 42:2001;2856-2860.
25. Li J., Tripathi B.J., Tripathi R.C. Modulation of pre-mRNA splicing and protein production of fibronectin by TGF-beta2 in porcine trabecular cells. Invest. Ophthalmol. Vis. Sci. 41:2000;3437-3443.
26. Matsuo T., Uchida H., Matsuo N. Bovine and porcine trabecular cells produce prostaglandin F2 alpha in response to cyclic mechanical stretching. Jap. J. Ophthalmol. 40:1996;289-296.
27. McMenamin P.G., Steptoe R.J. Normal anatomy of the aqueous outflow system in the domestic pig. J. Anat. 178:1991;65-77.
28. Nagase H. Stromelysin 1 and 2. Parks W.C., Mecham R.P. Matrix Metalloproteinases. 1998;43-84 Academic Press, San Diego, CA.
29. Nagase H., Woessner J.F.J. Matrix metalloproteinases. J. Biol. Chem. 274:1999;21491-21494.
30. Neckers L.M. Transferrin receptors regulate proliferation of normal and malignant B cells. Curr. Top. Microbiol. Immunol. 113:1984;62-68.
31. Park J.K., Tripathi R.C., Tripathi B.J., Barlow G.H. Tissue plasminogen activator in the trabecular endothelium. Invest. Ophthalmol. Vis. Sci. 28:1987;1341-1345.
32. Rao P.V., Deng P.F., Kumar J., Epstein D.L. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest. Ophthalmol. Vis. Sci. 42:2001;1029-1037.
33. Sato T., Roy S. Effect of high glucose on fibronectin expression and cell proliferation in trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 43:2002;170-175.
34. Schmid C. Insulin-like growth factors. Cell Biol. Int. 19:1995;445-457.
35. Somerville R.P.T., Oblander S.A., Apte A.A. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 4:2003;216. Epub 2003, May 29.
36. Sramek S.J., Wallow I.H., Bindley C., Sterken G. Fibronectin distribution in the rat eye. An immunohistochemical study. Invest. Ophthalmol. Vis. Sci. 28:1987;500-505.
37. Steely H.T., Browder S.L., Julian M.B., Miggans S.T., Wilson K.L., Clark A.F. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 33:1992;2242-2250.
38. Tripathi B.J., Tripathi R.C., Yang C., Millard C.B., Dixit V.M. Synthesis of a thrombospondin-like cytoadhesion molecule by cells of the trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 32:1991;181-188.
39. Tripathi B.J., Li T., Li J., Tran L., Tripathi R.C. Age-related changes in trabecular cells in vitro. Exp. Eye. Res. 64:1997;57-66.
40. Tripathi R.C., Borisuth N.S.C., Tripathi B.J. Detection, quantification, and significance of basic fibroblast growth factor in the aqueous humor of man, cat, dog and pig. Exp. Eye Res. 54:1992;447-454.
41. Tripathi R.C., Borisuth N.S.C., Li J., Tripathi B.J. Growth factors in the aqueous humor and their clinical significance. J. Glaucoma. 3:1994;248-258.
42. Tripathi R.C., Borisuth N.S.C., Li J., Tripathi B.J. Clinical implications of aqueous humor growth factors in glaucoma. Ritch R., Shields M.B., Krupin T. The Glaucomas. 2nd Ed. 1996;71-88 Mosby, St Louis.
43. Tripathi R.C., Borisuth N.S.C., Li J., Tripathi A.J., Tripathi B.J. Quantitative characterization of high- and low-affinity binding sites for basic fibroblast growth factor on trabecular cells of the eye. Exp. Eye Res. 64:1997;335-341.
44. Tripathi R.C., Li J., Chan W.F.A., Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-ß2. Exp. Eye Res. 59:1994;23-728.
45. Tripathi R.C., Li J., Tripathi B.J. Immunolocalization of bFGF in the trabecular meshwork and detection of its mRNA in trabecular cells. Exp. Eye Res. 58:1994;503-507.
46. Tripathi R.C., Park J.K., Tripathi B.J., Ts'ao C. Tissue plasminogen activator synthesis by trabecular cells and its implications for fibrinolytic therapy of the eye. Drug Dev. Res. 18:1989;245-254.
47. Tripathi R.C., Tripathi B.J., Haggerty C. Drug-induced glaucomas: mechanism and management. Drug Safety. 26:2003;749-767.
48. Wirtz M.K., Acott T.S., Samples J.R., Morrison J.C. Prospects for genetic intervention in primary open-angle glaucoma. Drugs Aging. 13:1998;333-340.
49. Worthen D.M., Cleveland P.H. Fibronectin production by cultured human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 23:1982;265-269.
50. Woessner J.F.J. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
51. Zhou L., Higginbotham E.J., Yue B.T. Effects of ascorbic acid on levels of fibronectin, laminin and collagen type 1 in bovine trabecular meshwork in organ culture. Curr. Eye Res. 17:1998;211-217.
52. Zhou L., Thompson W.J., Potter D.E. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 40:1999;1745-1752.